Loading…
LncRNA LITATS1 suppresses TGF‐β‐induced EMT and cancer cell plasticity by potentiating TβRI degradation
Epithelial cells acquire mesenchymal phenotypes through epithelial‐mesenchymal transition (EMT) during cancer progression. However, how epithelial cells retain their epithelial traits and prevent malignant transformation is not well understood. Here, we report that the long noncoding RNA LITATS1 ( L...
Saved in:
Published in: | The EMBO journal 2023-05, Vol.42 (10), p.e112806-n/a |
---|---|
Main Authors: | , , , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Epithelial cells acquire mesenchymal phenotypes through epithelial‐mesenchymal transition (EMT) during cancer progression. However, how epithelial cells retain their epithelial traits and prevent malignant transformation is not well understood. Here, we report that the long noncoding RNA
LITATS1
(
LINC01137
,
ZC3H12A‐DT
) is an epithelial gatekeeper in normal epithelial cells and inhibits EMT in breast and non‐small cell lung cancer cells. Transcriptome analysis identified
LITATS1
as a TGF‐β target gene.
LITATS1
expression is reduced in lung adenocarcinoma tissues compared with adjacent normal tissues and correlates with a favorable prognosis in breast and non‐small cell lung cancer patients.
LITATS1
depletion promotes TGF‐β‐induced EMT, migration, and extravasation in cancer cells. Unbiased pathway analysis demonstrated that
LITATS1
knockdown potently and selectively potentiates TGF‐β/SMAD signaling. Mechanistically,
LITATS1
enhances the polyubiquitination and proteasomal degradation of TGF‐β type I receptor (TβRI).
LITATS1
interacts with TβRI and the E3 ligase SMURF2, promoting the cytoplasmic retention of SMURF2. Our findings highlight a protective function of
LITATS1
in epithelial integrity maintenance through the attenuation of TGF‐β/SMAD signaling and EMT.
Synopsis
Epithelial‐mesenchymal transition (EMT) endows malignant cells with critical invasive properties, yet mechanisms controlling its induction remain poorly understood. This study identifies long noncoding RNA (lncRNA)
LITATS1
as a protective gatekeeper of epithelial cell identity and antagonist of TGF‐β‐induced EMT.
Transcriptome analysis of human mammary gland cells identifies
LITATS1
as a TGF‐β targeted epithelial lncRNA.
LITATS1
expression correlates with better prognosis in breast and non‐small cell lung cancer patients.
LITATS1
inhibits basal and TGF‐β‐induced EMT, cancer cell migration, and extravasation in xenografts.
LITATS1
attenuates TGF‐β/SMAD signaling by enhancing TβRI proteasomal degradation.
LITATS1
serves as a scaffold stabilizing interactions between TβRI and E3 ligase SMURF2, potentiating TβRI polyubiquitination.
Graphical Abstract
Long noncoding RNA
LITATS1
safeguards epithelial cell identity by inhibiting epithelial‐mesenchymal transition. |
---|---|
ISSN: | 0261-4189 1460-2075 |
DOI: | 10.15252/embj.2022112806 |